302 related articles for article (PubMed ID: 27655370)
21. [Multi-channel promotion of lung cancer progress by bone marrow derived mesenchymal stem cells in tumor microenvironment].
Luo D; Hu SY; Liu GX
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):85-91. PubMed ID: 29502366
[No Abstract] [Full Text] [Related]
22. Bit1 in anoikis resistance and tumor metastasis.
Jenning S; Pham T; Ireland SK; Ruoslahti E; Biliran H
Cancer Lett; 2013 Jun; 333(2):147-51. PubMed ID: 23376255
[TBL] [Abstract][Full Text] [Related]
23. Bit1-a novel regulator of astrocyte function during retinal development: proliferation, migration, and paracrine effects on vascular endothelial cell.
Liu Y; Ji J; Shao W; Luo M; Ma B
Hum Cell; 2019 Oct; 32(4):418-427. PubMed ID: 31368047
[TBL] [Abstract][Full Text] [Related]
24. Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin.
Nagathihalli NS; Massion PP; Gonzalez AL; Lu P; Datta PK
Mol Cancer Ther; 2012 Nov; 11(11):2362-72. PubMed ID: 22933707
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
[TBL] [Abstract][Full Text] [Related]
26. Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells.
Busaranon K; Plaimee P; Sritularak B; Chanvorachote P
J Nat Med; 2016 Jan; 70(1):18-27. PubMed ID: 26384689
[TBL] [Abstract][Full Text] [Related]
27. Pathological implication and function of Bcl2-inhibitor of transcription in ovarian serous papillary adenocarcinomas.
Hua W; Miao S; Zou W; Yang H; Chen BL
Neoplasma; 2013; 60(2):143-50. PubMed ID: 23259782
[TBL] [Abstract][Full Text] [Related]
28. NAC1/HMGB1 Signaling Pathway Is Associated with Epithelial-mesenchymal Transition, Invasion, and Metastasis of Lung Cancer Cell Line.
Liu Y; Du M; Song Y; Liu H; Xiang S
Ann Clin Lab Sci; 2018 Sep; 48(5):559-564. PubMed ID: 30373858
[TBL] [Abstract][Full Text] [Related]
29. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
30. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.
Roy BC; Kohno T; Iwakawa R; Moriguchi T; Kiyono T; Morishita K; Sanchez-Cespedes M; Akiyama T; Yokota J
Lung Cancer; 2010 Nov; 70(2):136-45. PubMed ID: 20207041
[TBL] [Abstract][Full Text] [Related]
31. NEK4 kinase regulates EMT to promote lung cancer metastasis.
Ding NH; Zhang L; Xiao Z; Rong ZX; Li Z; He J; Chen L; Ou DM; Liao WH; Sun LQ
J Cell Mol Med; 2018 Dec; 22(12):5877-5887. PubMed ID: 30247800
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
33. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
34. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
35. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer.
Chen X; Guan X; Zhang H; Xie X; Wang H; Long J; Cai T; Li S; Liu Z; Zhang Y
J Exp Clin Cancer Res; 2015 Jan; 34(1):3. PubMed ID: 25609022
[TBL] [Abstract][Full Text] [Related]
36. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
37. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
38. Homeobox C8 is a transcriptional repressor of E-cadherin gene expression in non-small cell lung cancer.
Zhang J; Yang M; Li D; Zhu S; Zou J; Xu S; Wang Y; Shi J; Li Y
Int J Biochem Cell Biol; 2019 Sep; 114():105557. PubMed ID: 31202850
[TBL] [Abstract][Full Text] [Related]
39. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.
Kumar S; Park SH; Cieply B; Schupp J; Killiam E; Zhang F; Rimm DL; Frisch SM
Mol Cell Biol; 2011 Oct; 31(19):4036-51. PubMed ID: 21746881
[TBL] [Abstract][Full Text] [Related]
40. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]